Overview

Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)

Status:
Completed
Trial end date:
2006-11-30
Target enrollment:
Participant gender:
Summary
This research focuses on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in very young children. The medication being used is methylphenidate (Ritalin); it is being studied to determine its safety and how well it works to treat ADHD in preschool-age children (3-5.5 year olds).
Phase:
Phase 3
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Methylphenidate